These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32664382)

  • 21. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues.
    Kiarash A; Boyd B; Lingwood CA
    J Biol Chem; 1994 Apr; 269(15):11138-46. PubMed ID: 8157640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.
    Ergonul Z; Clayton F; Fogo AB; Kohan DE
    Pediatr Nephrol; 2003 Mar; 18(3):246-53. PubMed ID: 12644917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    Jacewicz M; Clausen H; Nudelman E; Donohue-Rolfe A; Keusch GT
    J Exp Med; 1986 Jun; 163(6):1391-404. PubMed ID: 3519828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-assembled monolayers of globotriaosylceramide (Gb3) mimics: surface-specific affinity with shiga toxins.
    Miura Y; Sasao Y; Dohi H; Nishida Y; Kobayashi K
    Anal Biochem; 2002 Nov; 310(1):27-35. PubMed ID: 12413469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins.
    Neri P; Nagano SI; Yokoyama S; Dohi H; Kobayashi K; Miura T; Inazu T; Sugiyama T; Nishida Y; Mori H
    Microbiol Immunol; 2007; 51(6):581-92. PubMed ID: 17579269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.
    Keusch GT; Jacewicz M; Acheson DW; Donohue-Rolfe A; Kane AV; McCluer RH
    Infect Immun; 1995 Mar; 63(3):1138-41. PubMed ID: 7868240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histidine-tagged shiga toxin B subunit binding assay: simple and specific determination of gb3 content in mammalian cells.
    Shin IS; Nishikawa K; Maruyama H; Ishii S
    Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):522-7. PubMed ID: 16595957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism.
    Johansson KE; Ståhl AL; Arvidsson I; Loos S; Tontanahal A; Rebetz J; Chromek M; Kristoffersson AC; Johannes L; Karpman D
    Sci Rep; 2019 Oct; 9(1):14362. PubMed ID: 31591425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.
    Watanabe M; Igai K; Matsuoka K; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    Infect Immun; 2006 Mar; 74(3):1984-8. PubMed ID: 16495579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Shiga toxin glycosphingolipid receptors and their lipid membrane ensemble in primary human blood-brain barrier endothelial cells.
    Legros N; Dusny S; Humpf HU; Pohlentz G; Karch H; Müthing J
    Glycobiology; 2017 Jan; 27(1):99-109. PubMed ID: 27558838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retrograde transport of Shiga toxin 1 in human renal tubular epithelial cells].
    Kiyokawa N; Fujimoto J
    Nihon Rinsho; 2002 Jun; 60(6):1095-100. PubMed ID: 12078079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracellular trafficking of Shiga-toxin-B-subunit-functionalized spherulites.
    Bouter A; Delord B; Dransart E; Poirier C; Johannes L; van Effenterre D
    Biol Cell; 2008 Dec; 100(12):717-25. PubMed ID: 18564063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monovalent Gb3-/Gb2-derivatives conjugated with a phosphatidyl residue: a novel class of Shiga toxin-neutralizing agent.
    Neri P; Tokoro S; Yokoyama S; Miura T; Murata T; Nishida Y; Kajimoto T; Tsujino S; Inazu T; Usui T; Mori H
    Biol Pharm Bull; 2007 Sep; 30(9):1697-701. PubMed ID: 17827723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane lipids define small extracellular vesicle subtypes secreted by mesenchymal stromal cells.
    Lai RC; Lim SK
    J Lipid Res; 2019 Feb; 60(2):318-322. PubMed ID: 30154233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells.
    Takenouchi H; Kiyokawa N; Taguchi T; Matsui J; Katagiri YU; Okita H; Okuda K; Fujimoto J
    J Cell Sci; 2004 Aug; 117(Pt 17):3911-22. PubMed ID: 15265987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
    Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
    J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.
    Smith DC; Sillence DJ; Falguières T; Jarvis RM; Johannes L; Lord JM; Platt FM; Roberts LM
    Mol Biol Cell; 2006 Mar; 17(3):1375-87. PubMed ID: 16381816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.